DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven
If you suffered losses exceeding $50,000 in Biohaven between March 24, 2023 and May 14, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Biohaven Ltd. ('Biohaven' or the 'Company') (NYSE: BHVN) and reminds investors of the September 12, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) troriluzole's regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole's regulatory approval for this indication, were overstated; (2) BHV-7000's efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated; (3) all the foregoing, once revealed, was likely to have a significant negative impact on Biohaven's business and financial condition; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On May 14, 2025, Biohaven issued a press release 'announc[ing] that the Division of Neurology 1 within FDA's Office of Neuroscience informed the Company that they are extending the PDUFA date for the troriluzole new drug application (NDA) for the treatment of spinocerebellar ataxia (SCA) by three months to provide time for a full review of Biohaven's recent submissions related to information requests from the FDA.' The press release further stated that "[t]he Division also informed Biohaven that it is currently planning to hold an advisory committee meeting to discuss the application, but no date has been scheduled.'
On this news, Biohaven's stock price fell $3.84 per share, or 19.53%, to close at $15.82 per share on May 15, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Biohaven's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Biohaven class action, go to www.faruqilaw.com/BHVN or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d948d0e9-cd26-458d-bc47-d6862bd6ad82
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Jim Cramer Says 'We Should be in ConocoPhillips'
ConocoPhillips (NYSE:COP) is one of the stocks that Jim Cramer shed light on. When a caller asked about the company during the lightning round, Cramer commented: 'All right. Buy COP. Let me tell you, I just told Jeff Marks, my partner for the club, that we're in the wrong one now. Coterra is not delivering. We should be in ConocoPhillips. I just said it today. I'm not going to say it behind… I tell it to you, I say it to him. That's how I play it.' Pixabay/Public Domain ConocoPhillips (NYSE:COP) engages in the exploration, production, and transportation of crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids. Earlier in June, when a caller expressed their wish to sell COP shares for LLY shares, Cramer replied: 'I like your idea. I like your idea. I like your idea. I think Lily's at a great level, and Conoco is not nearly as all the oils go to like 4 or 5% yield, this is only three and a half. I want you to sell the Conoco and buy the Lilly. I like that idea.' While we acknowledge the potential of COP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Jim Cramer Says 'I Want You to Own This D-Wave'
D-Wave Quantum Inc. (NYSE:QBTS) is one of the stocks Jim Cramer reflected on. When a lightning round caller inquired about the stock, Cramer responded: 'I want you to own this D-Wave. Here's why I want D-Wave because one headline, one little story, and that stock goes up 10 points. I mean, I'm looking at stuff that is going up 10 points on nothing, and D-Wave has the ability to be able to do that because it's actually a real company.' A modern computer datacenter, running an advanced quantum computer system. D-Wave (NYSE:QBTS) develops quantum computing systems, software, and cloud services. The company provides hybrid quantum-classical solutions for complex problems in logistics, scheduling, optimization, drug discovery, and more across enterprise applications. During a May episode, Cramer mentioned the company and shared his bullish sentiment: 'Alright, I'm going to tell you something good. I think of the ones that are out there, this is the best, okay? How's that? This is the best. And if they got any good news beyond what they have, the stock probably goes to 25. There we go.' While we acknowledge the potential of QBTS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
6 Investing Moves That Benefit Millionaires, but Can Hurt the Middle Class
For members of the middle class, who only have a moderate amount of money to invest, every move you make counts and can have a big impact on your net worth. Millionaires, on the other hand, often have more room to play with a wider margin of error. Learn More: Read Next: Here, William 'Bill' London, a finance expert and partner at Kimura London & White LLP, explained what kind of moves millionaires can make that the middle class just can't, and how to think of investing. High Capital Investments When millionaires play with money, their investments often have qualities that middle class can't achieve, London said, including 'high capital, long horizons and privileged access to markets.' Millionaires are investing in hedge funds, venture capital or high property syndications that 'are frequently typified by limited accessibility, low liquidity and high levels of risk,' he said. The average middle-class person is lucky to have retirement accounts and maybe a high-yield savings account or money market account. Millionaires can invest big money because they have the financial buffer to incur 'little more than slight hardships instead of severe life-transforming effects, a situation that normally applies to most families holding middle incomes,' London explained. Find Out: Tax-Loss Harvesting Practice in Private Equity Tax-loss harvesting — essentially where investors reduce their taxable income by selling investments that have lost value — is another strategy millionaires use because they have 'substantial taxable investment portfolios and sophisticated tax planning,' London said. For the average person with a 401(k) and limited brokerage activity, the benefits are small and often not worth the complexity. Private equity, in general, is typically reserved for high-income earners because you have to commit large amounts of capital over longer durations, London explained. Millionaires have the kind of liquidity that allows for them to extract big sums of money without suffering to pay for their basic expenses. To a middle-class earner, liquidity might just mean a slim buffer 'to take care of unexpected situations, educational expenses or retirement goals which makes this investment strategy risky and often undesirable,' London said. Financing Through Debt Not only do millionaires have the ability to borrow against investment portfolios or real estate at low interest rates to reinvest or defer taxes, 'They have the liquidity and safety nets to handle downturns,' London said. A middle-class investor just isn't likely to have the financial buffer or willing to take a risk refinancing a home to invest. 'If the market moves in the wrong direction, they may not have the flexibility to recover.' Higher Risk Tolerance In a nutshell, millionaires can absorb losses without major lifestyle changes. 'They are able to take on high-risk, high-reward opportunities with patience and backup plans,' London pointed out. Middle-class investors usually cannot afford that luxury; a major loss could delay retirement or put essential life goals at risk. Using Tax-Friendly Instruments While almost anyone can get some kind of tax benefit for making a charitable contribution, where the benefits really kick in is at a level of money the middle class is unlikely to have. 'The tax benefits that are available for donor-advised funds and other sophisticated trusts are relevant more frequently in situations that involve large charitable gifts or intergenerational transfers of wealth,' London said. For most families, the administration and maintenance costs of setting up such funds and trusts alone would be worth more than their potential savings. Postponing Revenues and Lowering Current Period Profits Most middle-class people live, if not quite paycheck to paycheck, not far ahead of that, with a small emergency fund or buffer, and with every dollar of income counting. Millionaires, on the other hand, can actually delay income to affect their taxes. 'They may delay bonuses, use stock options, or receive investment returns structured to maximize long-term capital gains rates,' London explained. That's a flexibility the average person earning a fixed paycheck simply does not have. Suggestions for the Middle Class So maybe you're not a millionaire — yet. You still can and should continue to invest. London suggested that the best strategy for long-term investment success for middle-income investors is as follows: Building a diversified investment portfolio Participating in frequent contributions Reducing fees Avoiding emotion-driven decisions As compelling as these millionaires' big moves may look at a distance, London warned that it's 'often counterproductive' for the middle class to try to replicate them. 'Time-tested and simple investment methods often provide the most predictable results.' More From GOBankingRates How Much Money Is Needed To Be Considered Middle Class in Your State? This article originally appeared on 6 Investing Moves That Benefit Millionaires, but Can Hurt the Middle Class Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
